Abstract
Irisin, a newly discovered protein hormone that is secreted in response to low frequency whole body vibration (LFV), could be a promising post-stroke rehabilitation therapy for patients who are frail and cannot comply with regular rehabilitation therapy. Irisin is generated from a membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5). Aside from being highly expressed in muscle, FNDC5 is highly expressed in the brain. The cleaved form of FNDC5 was found in the cerebrospinal fluid as well as in various regions of the brain. Numerous studies suggest that irisin plays a key role in brain metabolism and inflammation regulation. Both the metabolism and inflammation govern stroke outcome, and in a published study, we demonstrated that LFV therapy following middle cerebral artery occlusion significantly reduced innate immune response, improved motor function and infarct volume in reproductively senescent female rats. The observed effect of LFV therapy could be working via irisin, therefore, the current review focuses to understand various aspects of irisin including its mechanism of action on the brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albasini, A., Krause, M., & Rembitzki, I. V. (2010). Using whole body vibration in physical therapy and sport: Clinical practice and treatment exercises. Churchill Livingstone/Elsevier.
Anker, S. D., Coats, A. J., Morley, J. E., Rosano, G., Bernabei, R., von Haehling, S., & Kalantar-Zadeh, K. (2014). Muscle wasting disease: A proposal for a new disease classification. Journal of Cachexia, Sarcopenia and Muscle, 5(1), 1–3. https://doi.org/10.1007/s13539-014-0135-0
Asadi, Y., Gorjipour, F., Behrouzifar, S., & Vakili, A. (2018). Irisin peptide protects brain against ischemic injury through reducing apoptosis and enhancing BDNF in a rodent model of stroke. Neurochemical Research, 43(8), 1549–1560. https://doi.org/10.1007/s11064-018-2569-9
Aydin, S., Kuloglu, T., Aydin, S., Kalayci, M., Yilmaz, M., Cakmak, T., Albayrak, S., Gungor, S., Colakoglu, N., & Ozercan, I. H. (2014). A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides, 61, 130–136. https://doi.org/10.1016/j.peptides.2014.09.014
Baba, Y., Ishikawa, S., Amagi, Y., Kayaba, K., Gotoh, T., & Kajii, E. (2010). Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause, 17(3), 506–510. https://doi.org/10.1097/gme.0b013e3181c7dd41
Bostrom, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Bostrom, E. A., Choi, J. H., Long, J. Z., Kajimura, S., Zingaretti, M. C., Vind, B. F., Tu, H., Cinti, S., Hojlund, K., Gygi, S. P., & Spiegelman, B. M. (2012). A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463–468. https://doi.org/10.1038/nature10777
Bramlett, H. M., Dietrich, W. D., Marcillo, A., Mawhinney, L. J., Furones-Alonso, O., Bregy, A., Peng, Y., Wu, Y., Pan, J., Wang, J., Guo, X. E., Bauman, W. A., Cardozo, C., & Qin, W. (2014). Effects of low intensity vibration on bone and muscle in rats with spinal cord injury. Osteoporosis International, 25(9), 2209–2219. https://doi.org/10.1007/s00198-014-2748-8
Brown, M. (2008). Skeletal muscle and bone: Effect of sex steroids and aging. Advances in Physiology Education, 32(2), 120–126. https://doi.org/10.1152/advan.90111.2008
Bushnell, C. D., Chaturvedi, S., Gage, K. R., Herson, P. S., Hurn, P. D., Jimenez, M. C., Kittner, S. J., Madsen, T. E., McCullough, L. D., McDermott, M., Reeves, M. J., & Rundek, T. (2018). Sex differences in stroke: Challenges and opportunities. Journal of Cerebral Blood Flow and Metabolism, 38(12), 2179–2191. https://doi.org/10.1177/0271678X18793324
Chang, K. V., Hsu, T. H., Wu, W. T., Huang, K. C., & Han, D. S. (2016). Association between sarcopenia and cognitive impairment: A systematic review and meta-analysis. Journal of the American Medical Directors Association, 17(12), 1164 e1167-1164 e1115. https://doi.org/10.1016/j.jamda.2016.09.013
Collaborators, G. B. D. S. (2019). Global, regional, and national burden of stroke, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 18(5), 439–458. https://doi.org/10.1016/S1474-4422(19)30034-1
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyere, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Writing Group for the European Working Group on Sarcopenia in Older, P., & the Extended Group for, E. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169
Davis, S. R., Lambrinoudaki, I., Lumsden, M., Mishra, G. D., Pal, L., Rees, M., Santoro, N., & Simoncini, T. (2015). Menopause. Nature Reviews. Disease Primers, 1, 15004. https://doi.org/10.1038/nrdp.2015.4
De Deyne, P. G., Hafer-Macko, C. E., Ivey, F. M., Ryan, A. S., & Macko, R. F. (2004). Muscle molecular phenotype after stroke is associated with gait speed. Muscle and Nerve, 30(2), 209–215. https://doi.org/10.1002/mus.20085
de Freitas, G. B., Lourenco, M. V., & De Felice, F. G. (2020). Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer’s disease. Journal of Neurochemistry, 155(6), 602–611. https://doi.org/10.1111/jnc.15039
de Rivero Vaccari, J. P., Patel, H. H., Brand, F. J., 3rd., Perez-Pinzon, M. A., Bramlett, H. M., & Raval, A. P. (2015). Estrogen receptor beta signaling alters cellular inflammasomes activity after global cerebral ischemia in reproductively senescence female rats. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13404
Dhanesha, N., Schnell, T., Rahmatalla, S., DeShaw, J., Thedens, D., Parker, B. M., Zimmerman, M. B., Pieper, A. A., Chauhan, A. K., & Leira, E. C. (2020). Low-frequency vibrations enhance thrombolytic therapy and improve stroke outcomes. Stroke. https://doi.org/10.1161/STROKEAHA.120.029405
Dhillon, R. J., & Hasni, S. (2017). Pathogenesis and management of sarcopenia. Clinics in Geriatric Medicine, 33(1), 17–26. https://doi.org/10.1016/j.cger.2016.08.002
Dun, S. L., Lyu, R. M., Chen, Y. H., Chang, J. K., Luo, J. J., & Dun, N. J. (2013). Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience, 240, 155–162. https://doi.org/10.1016/j.neuroscience.2013.02.050
Duncan, P. W., Zorowitz, R., Bates, B., Choi, J. Y., Glasberg, J. J., Graham, G. D., Katz, R. C., Lamberty, K., & Reker, D. (2005). Management of Adult Stroke Rehabilitation Care: A clinical practice guideline. Stroke, 36(9), e100-143. https://doi.org/10.1161/01.STR.0000180861.54180.FF
Efe, T. H., Acar, B., Ertem, A. G., Yayla, K. G., Algul, E., Yayla, C., Unal, S., Bilgin, M., Cimen, T., Kirbas, O., & Yeter, E. (2017). Serum irisin level can predict the severity of coronary artery disease in patients with stable angina. Korean Circ J, 47(1), 44–49. https://doi.org/10.4070/kcj.2016.0079
Enerback, S. (2010). Human brown adipose tissue. Cell Metabolism, 11(4), 248–252. https://doi.org/10.1016/j.cmet.2010.03.008
Fearon, K., Evans, W. J., & Anker, S. D. (2011). Myopenia-a new universal term for muscle wasting. Journal of Cachexia, Sarcopenia and Muscle, 2(1), 1–3. https://doi.org/10.1007/s13539-011-0025-7
Ferrer-Martinez, A., Ruiz-Lozano, P., & Chien, K. R. (2002). Mouse PeP: A novel peroxisomal protein linked to myoblast differentiation and development. Developmental Dynamics, 224(2), 154–167. https://doi.org/10.1002/dvdy.10099
Flansbjer, U. B., Miller, M., Downham, D., & Lexell, J. (2008). Progressive resistance training after stroke: Effects on muscle strength, muscle tone, gait performance and perceived participation. Journal of Rehabilitation Medicine, 40(1), 42–48. https://doi.org/10.2340/16501977-0129
Gingrich, A., Volkert, D., Kiesswetter, E., Thomanek, M., Bach, S., Sieber, C. C., & Zopf, Y. (2019). Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatrics, 19(1), 120. https://doi.org/10.1186/s12877-019-1115-1
Gong, Z., Pan, J., Shen, Q., Li, M., & Peng, Y. (2018). Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury. Journal of Neuroinflammation, 15(1), 242. https://doi.org/10.1186/s12974-018-1282-6
Greulich, T., Nell, C., Koepke, J., Fechtel, J., Franke, M., Schmeck, B., Haid, D., Apelt, S., Filipovic, S., Kenn, K., Janciauskiene, S., Vogelmeier, C., & Koczulla, A. R. (2014). Benefits of whole body vibration training in patients hospitalised for COPD exacerbations—A randomized clinical trial. BMC Pulmonary Medicine, 14, 60. https://doi.org/10.1186/1471-2466-14-60
Grygiel-Gorniak, B., & Puszczewicz, M. (2017). A review on irisin, a new protagonist that mediates muscle-adipose-bone-neuron connectivity. European Review for Medical and Pharmacological Sciences, 21(20), 4687–4693.
Guo, P., Jin, Z., Wu, H., Li, X., Ke, J., Zhang, Z., & Zhao, Q. (2019). Effects of irisin on the dysfunction of blood-brain barrier in rats after focal cerebral ischemia/reperfusion. Brain and Behavior: A Cognitive Neuroscience Perspective, 9(10), e01425. https://doi.org/10.1002/brb3.1425
Hafer-Macko, C. E., Ryan, A. S., Ivey, F. M., & Macko, R. F. (2008). Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies. Journal of Rehabilitation Research and Development, 45(2), 261–272. https://doi.org/10.1682/jrrd.2007.02.0040
Handschin, C., & Spiegelman, B. M. (2008). The role of exercise and PGC1alpha in inflammation and chronic disease. Nature, 454(7203), 463–469. https://doi.org/10.1038/nature07206
Huh, J. Y., Mougios, V., Skraparlis, A., Kabasakalis, A., & Mantzoros, C. S. (2014). Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism, 63(7), 918–921. https://doi.org/10.1016/j.metabol.2014.04.001
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012). FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 61(12), 1725–1738. https://doi.org/10.1016/j.metabol.2012.09.002
Iemura, S., Kawao, N., Okumoto, K., Akagi, M., & Kaji, H. (2020). Role of irisin in androgen-deficient muscle wasting and osteopenia in mice. Journal of Bone and Mineral Metabolism, 38(2), 161–171. https://doi.org/10.1007/s00774-019-01043-7
Jauch, E. C., Saver, J. L., Adams, H. P., Jr., Bruno, A., Connors, J. J., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Jr., Qureshi, A. I., Rosenfield, K., Scott, P. A., Summers, D. R., Wang, D. Z., Wintermark, M., Yonas, H., American Heart Association Stroke, C., Council on Cardiovascular, N., Council on Peripheral Vascular, D., & Council on Clinical, C. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870–947. https://doi.org/10.1161/STR.0b013e318284056a
Jedrychowski, M. P., Wrann, C. D., Paulo, J. A., Gerber, K. K., Szpyt, J., Robinson, M. M., Nair, K. S., Gygi, S. P., & Spiegelman, B. M. (2015). Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metabolism, 22(4), 734–740. https://doi.org/10.1016/j.cmet.2015.08.001
Kapogiannis, D., & Mattson, M. P. (2011). Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer’s disease. Lancet Neurology, 10(2), 187–198. https://doi.org/10.1016/S1474-4422(10)70277-5
Karlamangla, A. S., Burnett-Bowie, S. M., & Crandall, C. J. (2018). Bone health during the menopause transition and beyond. Obstetrics and Gynecology Clinics of North America, 45(4), 695–708. https://doi.org/10.1016/j.ogc.2018.07.012
Kerr, N., Garcia-Contreras, M., Abbassi, S., Mejias, N. H., Desousa, B. R., Ricordi, C., Dietrich, W. D., Keane, R. W., & de Rivero Vaccari, J. P. (2018a). Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke. Frontiers in Molecular Neuroscience, 11, 309. https://doi.org/10.3389/fnmol.2018.00309
Kerr, N., Lee, S. W., Perez-Barcena, J., Crespi, C., Ibanez, J., Bullock, M. R., Dietrich, W. D., Keane, R. W., & de Rivero Vaccari, J. P. (2018b). Inflammasome proteins as biomarkers of traumatic brain injury. PLoS ONE, 13(12), e0210128. https://doi.org/10.1371/journal.pone.0210128
Khadilkar, S. S. (2019). Musculoskeletal disorders and menopause. Journal of Obstetrics and Gynaecology of India, 69(2), 99–103. https://doi.org/10.1007/s13224-019-01213-7
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V. A., Novick, S. J., Strutzenberg, T. S., Pascal, B. D., Le, P. T., Brooks, D. J., Roche, A. M., Gerber, K. K., Mattheis, L., Chen, W., Tu, H., … Spiegelman, B. M. (2018). Irisin mediates effects on bone and fat via alphaV integrin receptors. Cell, 175(7), 1756–1768. https://doi.org/10.1016/j.cell.2018.10.025
Kim, H. J., So, B., Choi, M., Kang, D., & Song, W. (2015). Resistance exercise training increases the expression of irisin concomitant with improvement of muscle function in aging mice and humans. Experimental Gerontology, 70, 11–17. https://doi.org/10.1016/j.exger.2015.07.006
Kim, Y., Park, J., & Choi, Y. K. (2019). The role of astrocytes in the central nervous system focused on BK channel and heme oxygenase metabolites: A review. Antioxidants. https://doi.org/10.3390/antiox8050121
Lee, H. J., Lee, J. O., Kim, N., Kim, J. K., Kim, H. I., Lee, Y. W., Kim, S. J., Choi, J. I., Oh, Y., Kim, J. H., Suyeon, H., Park, S. H., & Kim, H. S. (2015). Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Molecular Endocrinology, 29(6), 873–881. https://doi.org/10.1210/me.2014-1353
Li, D. J., Li, Y. H., Yuan, H. B., Qu, L. F., & Wang, P. (2017). The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism, 68, 31–42. https://doi.org/10.1016/j.metabol.2016.12.003
Li, D. J., Sun, S. J., Fu, J. T., Ouyang, S. X., Zhao, Q. J., Su, L., Ji, Q. X., Sun, D. Y., Zhu, J. H., Zhang, G. Y., Ma, J. W., Lan, X. T., Zhao, Y., Tong, J., Li, G. Q., Shen, F. M., & Wang, P. (2021). NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. Theranostics, 11(9), 4381–4402. https://doi.org/10.7150/thno.53652
Liu, L., Zhang, Q., Li, M., Wang, N., Li, C., Song, D., Shen, X., Luo, L., Fan, Y., Xie, H., & Wu, Y. (2021). Early post-stroke electroacupuncture promotes motor function recovery in post-ischemic rats by increasing the blood and brain irisin. Neuropsychiatric Disease and Treatment, 17, 695–702. https://doi.org/10.2147/NDT.S290148
Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Goncalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., Berman, H., Guerra, L. A., Forny-Germano, L., Meier, S., Wilcock, D. M., de Souza, J. M., Alves-Leon, S., Prado, V. F., Prado, M. A. M., … De Felice, F. G. (2019). Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine, 25(1), 165–175. https://doi.org/10.1038/s41591-018-0275-4
Mayo, N. E., Wood-Dauphinee, S., Cote, R., Durcan, L., & Carlton, J. (2002). Activity, participation, and quality of life 6 months poststroke. Archives of Physical Medicine and Rehabilitation, 83(8), 1035–1042. https://doi.org/10.1053/apmr.2002.33984
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011). Menopause and sarcopenia: A potential role for sex hormones. Maturitas, 68(4), 331–336. https://doi.org/10.1016/j.maturitas.2011.01.014
Moon, H. S., Dincer, F., & Mantzoros, C. S. (2013). Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19–7 hippocampal cell lines. Metabolism, 62(8), 1131–1136. https://doi.org/10.1016/j.metabol.2013.04.007
Morreale, M., Marchione, P., Pili, A., Lauta, A., Castiglia, S. F., Spallone, A., Pierelli, F., & Giacomini, P. (2016). Early versus delayed rehabilitation treatment in hemiplegic patients with ischemic stroke: Proprioceptive or cognitive approach? European Journal of Physical and Rehabilitation Medicine, 52(1), 81–89.
Morris-Blanco, K. C., Cohan, C. H., Neumann, J. T., Sick, T. J., & Perez-Pinzon, M. A. (2014). Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex. Journal of Cerebral Blood Flow and Metabolism, 34(6), 1024–1032. https://doi.org/10.1038/jcbfm.2014.51
Narici, M. V., & Maffulli, N. (2010). Sarcopenia: Characteristics, mechanisms and functional significance. British Medical Bulletin, 95, 139–159. https://doi.org/10.1093/bmb/ldq008
Nie, Y., Dai, B., Guo, X., & Liu, D. (2020). Cleavage of FNDC5 and insights into its maturation process. Molecular and Cellular Endocrinology, 510, 110840. https://doi.org/10.1016/j.mce.2020.110840
Nie, Y., & Liu, D. (2017). N-Glycosylation is required for FDNC5 stabilization and irisin secretion. The Biochemical Journal, 474(18), 3167–3177. https://doi.org/10.1042/BCJ20170241
Nozoe, M., Kanai, M., Kubo, H., Yamamoto, M., Shimada, S., & Mase, K. (2019). Prestroke sarcopenia and stroke severity in elderly patients with acute stroke. Journal of Stroke and Cerebrovascular Diseases, 28(8), 2228–2231. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.05.001
Palmer, K., Vetrano, D. L., Padua, L., Romano, V., Rivoiro, C., Scelfo, B., Marengoni, A., Bernabei, R., & Onder, G. (2019). Frailty syndromes in persons with cerebrovascular disease: A systematic review and meta-analysis. Frontiers in Neurology, 10, 1255. https://doi.org/10.3389/fneur.2019.01255
Paolucci, S., Antonucci, G., Grasso, M. G., Morelli, D., Troisi, E., Coiro, P., & Bragoni, M. (2000). Early versus delayed inpatient stroke rehabilitation: A matched comparison conducted in Italy. Archives of Physical Medicine and Rehabilitation, 81(6), 695–700. https://doi.org/10.1016/s0003-9993(00)90095-9
Park, Y. J., Park, S. W., & Lee, H. S. (2018). Comparison of the effectiveness of whole body vibration in stroke patients: A meta-analysis. BioMed Research International, 2018, 5083634. https://doi.org/10.1155/2018/5083634
Peng, J., Deng, X., Huang, W., Yu, J. H., Wang, J. X., Wang, J. P., Yang, S. B., Liu, X., Wang, L., Zhang, Y., Zhou, X. Y., Yang, H., He, Y. Z., & Xu, F. Y. (2017). Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway. Molecular Immunology, 91, 185–194. https://doi.org/10.1016/j.molimm.2017.09.014
Perakakis, N., Triantafyllou, G. A., Fernandez-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017). Physiology and role of irisin in glucose homeostasis. Nature Reviews Endocrinology, 13(6), 324–337. https://doi.org/10.1038/nrendo.2016.221
Phillips, S. K., Rook, K. M., Siddle, N. C., Bruce, S. A., & Woledge, R. C. (1993). Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science, 84(1), 95–98. https://doi.org/10.1042/cs0840095
Piya, M. K., Harte, A. L., Sivakumar, K., Tripathi, G., Voyias, P. D., James, S., Sabico, S., Al-Daghri, N. M., Saravanan, P., Barber, T. M., Kumar, S., Vatish, M., & McTernan, P. G. (2014). The identification of irisin in human cerebrospinal fluid: Influence of adiposity, metabolic markers, and gestational diabetes. American Journal of Physiology. Endocrinology and Metabolism, 306(5), E512-518. https://doi.org/10.1152/ajpendo.00308.2013
Prabhakaran, S., Ruff, I., & Bernstein, R. A. (2015). Acute stroke intervention: A systematic review. JAMA, 313(14), 1451–1462. https://doi.org/10.1001/jama.2015.3058
Rathnayake, N., Alwis, G., Lenora, J., & Lekamwasam, S. (2021). Factors associated with measures of sarcopenia in pre and postmenopausal women. BMC Women’s Health, 21(1), 5. https://doi.org/10.1186/s12905-020-01153-9
Raval, A. P., Schatz, M., Bhattacharya, P., d’Adesky, N., Rundek, T., Dietrich, W. D., & Bramlett, H. M. (2018). Whole body vibration therapy after ischemia reduces brain damage in reproductively senescent female rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19092749
Rees, S. S., Murphy, A. J., & Watsford, M. L. (2009). Effects of whole body vibration on postural steadiness in an older population. Journal of Science and Medicine in Sport, 12(4), 440–444. https://doi.org/10.1016/j.jsams.2008.02.002
Rempe, R. G., Hartz, A. M. S., & Bauer, B. (2016). Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. Journal of Cerebral Blood Flow and Metabolism, 36(9), 1481–1507. https://doi.org/10.1177/0271678X16655551
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Belen Crujeiras, A., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013). FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE, 8(4), e60563. https://doi.org/10.1371/journal.pone.0060563
Schatz, M., Saravanan, S., d’Adesky, N. D., Bramlett, H., Perez-Pinzon, M. A., & Raval, A. P. (2020). Osteocalcin, ovarian senescence, and brain health. Frontiers in Neuroendocrinology, 59, 100861. https://doi.org/10.1016/j.yfrne.2020.100861
Scherbakov, N., & Doehner, W. (2011). Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. Journal of Cachexia, Sarcopenia and Muscle, 2(1), 5–8. https://doi.org/10.1007/s13539-011-0024-8
Scherbakov, N., Sandek, A., & Doehner, W. (2015). Stroke-related sarcopenia: Specific characteristics. Journal of the American Medical Directors Association, 16(4), 272–276. https://doi.org/10.1016/j.jamda.2014.12.007
Schumacher, M. A., Chinnam, N., Ohashi, T., Shah, R. S., & Erickson, H. P. (2013). The structure of irisin reveals a novel intersubunit beta-sheet fibronectin type III (FNIII) dimer: Implications for receptor activation. Journal of Biological Chemistry, 288(47), 33738–33744. https://doi.org/10.1074/jbc.M113.516641
Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2011). Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. The Journal of Clinical Investigation, 121(1), 96–105. https://doi.org/10.1172/JCI44271
Shiraishi, A., Yoshimura, Y., Wakabayashi, H., & Tsuji, Y. (2018). Prevalence of stroke-related sarcopenia and its association with poor oral status in post-acute stroke patients: Implications for oral sarcopenia. Clinical Nutrition, 37(1), 204–207. https://doi.org/10.1016/j.clnu.2016.12.002
Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., Coenen-Schimke, J. M., Rys, P., & Nair, K. S. (2005). Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training. Journal of Applied Physiology (1985), 99(1), 95–102. https://doi.org/10.1152/japplphysiol.00129.2005
Su, Y., Yuki, M., & Otsuki, M. (2020). Prevalence of stroke-related sarcopenia: A systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 29(9), 105092. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105092
Tsuchiya, Y., Ando, D., Takamatsu, K., & Goto, K. (2015). Resistance exercise induces a greater irisin response than endurance exercise. Metabolism, 64(9), 1042–1050. https://doi.org/10.1016/j.metabol.2015.05.010
Tu, T., Yin, S., Pang, J., Zhang, X., Zhang, L., Zhang, Y., Xie, Y., Guo, K., Chen, L., Peng, J., & Jiang, Y. (2021). Irisin contributes to neuroprotection by promoting mitochondrial biogenesis after experimental subarachnoid hemorrhage. Frontiers in Aging Neuroscience, 13, 640215. https://doi.org/10.3389/fnagi.2021.640215
Tu, W. J., Qiu, H. C., Cao, J. L., Liu, Q., Zeng, X. W., & Zhao, J. Z. (2018). Decreased concentration of irisin is associated with poor functional outcome in ischemic stroke. Neurotherapeutics, 15(4), 1158–1167. https://doi.org/10.1007/s13311-018-0651-2
Varela-Rodriguez, B. M., Pena-Bello, L., Juiz-Valina, P., Vidal-Bretal, B., Cordido, F., & Sangiao-Alvarellos, S. (2016). FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Science and Reports, 6, 29898. https://doi.org/10.1038/srep29898
Wang, K., Li, H., Wang, H., Wang, J. H., Song, F., & Sun, Y. (2018). Irisin exerts neuroprotective effects on cultured neurons by regulating astrocytes. Mediators of Inflammation, 2018, 9070341. https://doi.org/10.1155/2018/9070341
Wang, S., & Pan, J. (2016). Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism. Biochemical and Biophysical Research Communications, 474(1), 22–28. https://doi.org/10.1016/j.bbrc.2016.04.047
Wilkinson, S. B., Phillips, S. M., Atherton, P. J., Patel, R., Yarasheski, K. E., Tarnopolsky, M. A., & Rennie, M. J. (2008). Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. Journal of Physiology, 586(15), 3701–3717. https://doi.org/10.1113/jphysiol.2008.153916
Winovich, D. T., Longstreth, W. T., Jr., Arnold, A. M., Varadhan, R., Zeki Al Hazzouri, A., Cushman, M., Newman, A. B., & Odden, M. C. (2017). Factors associated with ischemic stroke survival and recovery in older adults. Stroke, 48(7), 1818–1826. https://doi.org/10.1161/STROKEAHA.117.016726
Wrann, C. D. (2015). FNDC5/irisin—Their role in the nervous system and as a mediator for beneficial effects of exercise on the brain. Brain Plast, 1(1), 55–61. https://doi.org/10.3233/BPL-150019
Wrann, C. D., White, J. P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J. D., Greenberg, M. E., & Spiegelman, B. M. (2013). Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metabolism, 18(5), 649–659. https://doi.org/10.1016/j.cmet.2013.09.008
Wu, J., Dou, Y., Liu, W., Zhao, Y., & Liu, X. (2020). Osteocalcin improves outcome after acute ischemic stroke. Aging, 12(1), 387–396. https://doi.org/10.18632/aging.102629
Wu, X., & Reddy, D. S. (2012). Integrins as receptor targets for neurological disorders. Pharmacology & Therapeutics, 134(1), 68–81. https://doi.org/10.1016/j.pharmthera.2011.12.008
Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., & Yi, F. (2014). NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. Journal of Cerebral Blood Flow and Metabolism, 34(4), 660–667. https://doi.org/10.1038/jcbfm.2013.242
Yang, J. L., Mukda, S., & Chen, S. D. (2018). Diverse roles of mitochondria in ischemic stroke. Redox Biology, 16, 263–275. https://doi.org/10.1016/j.redox.2018.03.002
Young, M. F., Valaris, S., & Wrann, C. D. (2019). A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases. Progress in Cardiovascular Diseases, 62(2), 172–178. https://doi.org/10.1016/j.pcad.2019.02.007
Yu, Q., Li, G., Ding, Q., Tao, L., Li, J., Sun, L., Sun, X., & Yang, Y. (2020). Irisin protects brain against ischemia/reperfusion injury through suppressing TLR4/MyD88 pathway. Cerebrovascular Diseases, 49(4), 346–354. https://doi.org/10.1159/000505961
Zhang, J., & Zhang, W. (2016). Can irisin be a linker between physical activity and brain function? Biomolecular Concepts, 7(4), 253. https://doi.org/10.1515/bmc-2016-0012
Zhang, Y., Song, H., Zhang, Y., Wu, F., Mu, Q., Jiang, M., Wang, F., Zhang, W., Li, L., Shao, L., Li, S., Yang, L., Zhang, M., Wu, Q., & Tang, D. (2016). Irisin inhibits atherosclerosis by promoting endothelial proliferation through microRNA126–5p. Journal of the American Heart Association. https://doi.org/10.1161/JAHA.116.004031
Zhao, J., Su, Z., Qu, C., & Dong, Y. (2017). Effects of 12 weeks resistance training on serum irisin in older male adults. Frontiers in Physiology, 8, 171. https://doi.org/10.3389/fphys.2017.00171
Acknowledgements
This work was supported by an Endowment from Drs. Chantal and Peritz Scheinberg (Ami P. Raval), Florida Department of Heath # 7JK01 (Helen M. Bramlett & Ami P. Raval), and # 20K09 funds (Ami P. Raval).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huberman, M.A., d’Adesky, N.D., Niazi, Q.B. et al. Irisin-Associated Neuroprotective and Rehabilitative Strategies for Stroke. Neuromol Med 24, 62–73 (2022). https://doi.org/10.1007/s12017-021-08666-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-021-08666-y